Development and validation of a Screening Tool to Evaluate and Warrant Anticoagulation Treatment prior to Discharge in inpatients with Atrial Fibrillation (STEWAR

Anticoagulants / therapeutic use Atrial Fibrillation / diagnosis Cross-Sectional Studies Humans Inpatients Patient Discharge Risk Assessment
Anticoagulant therapy Atrial fibrillation Clinical decision support Screening tool Stroke prevention

Journal

International journal of medical informatics
ISSN: 1872-8243
Titre abrégé: Int J Med Inform
Pays: Ireland
ID NLM: 9711057

Informations de publication

Date de publication:
10 2021
Historique:
received: 01 04 2021
revised: 10 08 2021
accepted: 15 08 2021
pubmed: 27 8 2021
medline: 25 2 2023
entrez: 26 8 2021
Statut: ppublish

Résumé

Anticoagulation is highly effective for stroke prevention in atrial fibrillation (AF), reducing the risk by about 64%. Despite overwhelming evidence in support of anticoagulation, up to 40% of AF patients remain untreated. We aimed to develop and validate STEWAR STEWAR A tool to screen for un(der)treated AF was developed and embedded into the EHR. Sensitivity and specificity for AF diagnosis were 98.4% and 87.6%, respectively. Overall sensitivity and specificity for identification of a CHA STEWAR

Identifiants

DOI: 10.1016/j.ijmedinf.2021.104555 PMID: 34438318
pubmed: 34438318
pii: S1386-5056(21)00181-7
doi: 10.1016/j.ijmedinf.2021.104555
pii:
doi:

Substances chimiques

Anticoagulants 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

104555

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Charlotte Quintens (C)

Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium; Pharmacy Department, University Hospitals Leuven, Leuven, Belgium. Electronic address: charlotte.quintens@uzleuven.be.

Lorenz Van der Linden (L)

Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium; Pharmacy Department, University Hospitals Leuven, Leuven, Belgium. Electronic address: lorenz.vanderlinden@uzleuven.be.

Kaat Meeusen (K)

Department of Cardiology, University Hospitals Leuven, Leuven, Belgium. Electronic address: karolien.meeusen@uzleuven.be.

Egon Nijns (E)

Department of Information Technology, University Hospitals Leuven, Leuven, Belgium. Electronic address: egon.nijns@uzleuven.be.

Rik Willems (R)

Department of Cardiology, University Hospitals Leuven, Leuven, Belgium; Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium. Electronic address: rik.willems@uzleuven.be.

Isabel Spriet (I)

Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium; Pharmacy Department, University Hospitals Leuven, Leuven, Belgium. Electronic address: isabel.spriet@uzleuven.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Agents hématologiques › Anticoagulants › Development and validation of a Screening Tool...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Troubles du rythme cardiaque › Fibrillation auriculaire › Development and validation of a Screening Tool...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études transversales › Development and validation of a Screening Tool...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Development and validation of a Screening Tool...
questionsmedicales.fr › Personnes › Patients › Patients hospitalisés › Development and validation of a Screening Tool...
questionsmedicales.fr › Administration des services de santé › Gestion des soins aux patients › Services de santé polyvalents › Soins de santé primaires › Continuité des soins › Sortie du patient › Development and validation of a Screening Tool...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Appréciation des risques › Development and validation of a Screening Tool...